Functional domains of δ- and μ-opioid receptors responsible for adenylyl cyclase inhibition

Receptors and Channels

Volumn 7, Issue 3, 2000, Pages 199-212

  Megaritis, G ^a   Merkouris, M ^b   Georgoussi, Z ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adenylyl cyclase; Functional domains; G protein; Opioid receptors

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; PERTUSSIS TOXIN; PROTEIN SUBUNIT; SIGMA OPIATE RECEPTOR; SYNTHETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEINS; MICE; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

ANIMALIA; MURINAE;

EID: 0034441889     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bayewitch ML Avidor-Reiss T Levy R Pfeuffer T Nevo I Simonds WF and Vogel Z (1998) FASEB J 11 1019-1025.
2. Berman DM and Gilman AG (1998) J Biol Chem 273 1269-1272.
3. Bommakanti RK Dratz EA Siemsen DW and Jesaitis AJ (1995) Biochemistry 34 6720-6728.
4. Bourne (1993) Nature 366 628-629.
5. Chakrabarti S Law P-Y Loh HH (1995) Mol Brain Res 30 269-278.
6. Chiu TT Yung LY and Wong YH (1996) Mol Pharmacol 50 1651-1657.
7. Cotecchia S Ostrowski J Kjelsberg MA Caron MG and Lefkowitz RJ (1992) J Biol Chem 267 1633-1639.
8. Evans CJ Keith DE Morrison H Magendzo K and Edwards RH (1992) Science (Washington DC) 258 1952-1955.
9. Georgoussi Z Carr C and Milligan G (1993) Mol Pharmacol 44 62-69.
10. Georgoussi Z Milligan G and Zioudrou C (1995) Biochem J 306 71-75.
11. Georgoussi Z Merkouris M Mullaney I Megaritis G Carr G Zioudrou C and Milligan G (1997) Biochim Biophys Acta 1359 263-274.
12. Goldsmith P Gierschik P Milligan G Unson C Vinitsky R Malech HL and Spiegel AM (1987) J Biol Chem 262 14683-14688.
13. Hamm HE Deretic D Arendt A Hargrave A Koenig B and Hofman KP (1988) Science (Washington DC) 241 832-835.
14. Houslay MD and Milligan G (1997) Trends Biochem Sci 22 217-224.
15. Hurley JH (1999) J Biol Chem 274 7599-7602.
16. Kieffer BL Befort K Gaveriaux-Ruff C and Hirth CG (1992) Proc Natl Acad Sci USA 89 12048-12052.
17. Konig B Arendt A McDowell JH Kahlert M Hargrave PA and Hofmann KP (1989) Proc Natl Acad Sci USA 86 6878-6882.
18. Laugwitz K-L Offermanns S Spicher K and Schultz G (1993) Neuron 10 233-242.
19. Liu J Conklin BR Blin N Yun J and Wess J (1995) Proc Natl Acad Sci USA 92 11642-11646.
20. Lowry OH Rosbrough NJ Farr AL and Randall RJ (1951) J Biol Chem 193 265-275.
21. Mc Kenzie FR and Milligan G (1990) Biochem J 267 391-398.
22. Merkouris M Dragatsis I Megaritis G Konidakis G Zioudrou C Milligan G and Georgoussi Z (1996) Mol Pharmacol 50 985-993.
23. Merkouris M Mullaney I Georgoussi Z and Milligan G (1997) J Neurochem 69 2115-2122.
24. Milligan G (1990) "Pertussis toxin-sensitive GTP-binding proteins in neuronal tissues: recent insights into expression and function", in Current Aspects of the Neurosciences (eds Osborne NN) Vol 2 77-107 Macmillan Press.
25. Mullaney I Carr C and Milligan G (1996) Biochem J 315 227-234.
26. Munch G Dees C Hekman M and Palm D (1991) Eur J Biochem 198 357-364.
27. O'Dowd BF Hnatowich M Regan JW Leader WM Caron MG and Lefkowitz RJ (1988) J Biol Chem 263 15985-15992.
28. Offermanns S Schulz G and Rosenthal W (1991) J Biol Chem 266 3365-3368.
29. Ovchinnikov VA Abdulaev NG and Bogachuk AS (1988) FEBS Lett 230 1-5.
30. Palm D Munch G Dees C Malek D and Hekman M (1990) FEBS Lett 254 89-93.
31. Prossnitz ER Quehenberger O Cochrane CG and Ye RD (1993) Biochem J 294 581-587.
32. Richardson A Demoliou-Mason C and Barnard EA (1992) Proc Natl Acad Sci USA 89 10198-10202.
33. Savarase TM and Fraser CM (1992) Biochem J 283 1-19.
34. Schreider RE Prossnitz ER Ye RD Cochrane CG and Bokoch GM (1994) J Biol Chem 269 326-331.
35. Shah BH and Milligan G (1994) Mol Pharmacol 46 1-7.
36. Sprang SR (1997) Annu Rev Biochem 6 639-678.
37. Standifer KM Pitha J and Baker SP (1989) Naunym-Schmiedeberg's Arch Pharmacol 339 129-137.
38. Standifer KM and Pasternak GW (1997) Cell Signal 9 237-248.
39. Taylor JM Jacob-Mosier G Lawton RG Remmers AE and Neubig RR (1994) J Biol Chem 269 27618-27624.
40. Tian W-N Duzic E Lanier SM Deth RC (1994) Mol Pharmacol 45 524-531.
41. Uhl GR Childers S and Pasternak G (1994) Trends Neurosci 17 89-101.
42. Varrault A Nguyen DL McClue S Harris B Jouin P and Bockaert J (1994) J Biol Chem 269 16720-16725.
43. Voss T Wallner E Czernilofsky AP and Freissmuth M (1993) J Biol Chem 268 4637-4642.
44. Wess J (1997) FASEB J 11 346-354.